Antibiotic therapy for abdominal infection

Area of Science:

• Infectious Diseases
• Pharmacology
• Surgical Infections

Background:

• Abdominal infections necessitate a multi-faceted treatment approach including resuscitation, drainage, source control, and antimicrobial therapy.
• Antimicrobial selection ideally targets prevalent pathogens like Escherichia coli and Bacteroides species, balancing efficacy, safety, cost, and resistance.
• The necessity of expanded antimicrobial coverage for hospital-acquired infections remains a subject of debate.

Purpose of the Study:

• To review current treatment strategies for abdominal infections.
• To discuss the role of antimicrobial agents, including new developments and controversies.
• To highlight challenges in clinical trials for abdominal infection therapies.

Main Methods:

• Literature review of clinical trials and studies on abdominal infection treatment.
• Analysis of established and emerging antimicrobial regimens.
• Discussion of controversies and recent developments in the field.

Main Results:

• Numerous single-agent and combination regimens are effective, primarily based on coverage of Escherichia coli and Bacteroides.
• Antifungal therapy is indicated for Candida infections in specific patient groups.
• Recent developments include new antibiotic combinations, once-daily aminoglycoside use, and evidence supporting shorter treatment courses.

Conclusions:

• Optimal antimicrobial therapy for abdominal infections requires careful consideration of pathogen coverage, safety, cost, and potential for resistance.
• Newer agents and strategies like oral therapy and shorter treatment durations are emerging.
• Improving clinical trials by controlling for surgical intervention adequacy is crucial.